US Environmental Protection Agency, Great Lakes Toxicology and Ecology Division, Duluth, Minnesota.
US Environmental Protection Agency, Integrated Systems Toxicology Division, Research Triangle Park, North Carolina.
Environ Toxicol Chem. 2021 Apr;40(4):1155-1170. doi: 10.1002/etc.4968. Epub 2021 Mar 10.
The present study evaluated whether in vitro measures of aromatase inhibition as inputs into a quantitative adverse outcome pathway (qAOP) construct could effectively predict in vivo effects on 17β-estradiol (E2) and vitellogenin (VTG) concentrations in female fathead minnows. Five chemicals identified as aromatase inhibitors in mammalian-based ToxCast assays were screened for their ability to inhibit fathead minnow aromatase in vitro. Female fathead minnows were then exposed to 3 of those chemicals: letrozole, epoxiconazole, and imazalil in concentration-response (5 concentrations plus control) for 24 h. Consistent with AOP-based expectations, all 3 chemicals caused significant reductions in plasma E2 and hepatic VTG transcription. Characteristic compensatory upregulation of aromatase and follicle-stimulating hormone receptor (fshr) transcripts in the ovary were observed for letrozole but not for the other 2 compounds. Considering the overall patterns of concentration-response and temporal concordance among endpoints, data from the in vivo experiments strengthen confidence in the qualitative relationships outlined by the AOP. Quantitatively, the qAOP model provided predictions that fell within the standard error of measured data for letrozole but not for imazalil and epoxiconazole. However, the inclusion of measured plasma concentrations of the test chemicals as inputs improved model predictions, with all predictions falling within the range of measured values. Results highlight both the utility and limitations of the qAOP and its potential use in 21st century ecotoxicology. Environ Toxicol Chem 2021;40:1155-1170. © 2020 SETAC. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
本研究评估了体外芳香酶抑制测定作为定量不良结局途径(qAOP)构建的输入,是否能有效预测对雌性黑头呆鱼 17β-雌二醇(E2)和卵黄蛋白原(VTG)浓度的体内影响。在哺乳动物基于 ToxCast 测定的芳香酶抑制剂中筛选了 5 种化学物质,以评估其抑制黑头呆鱼芳香酶的能力。然后,将 3 种化学物质(来曲唑、环氧氯丙烷和双氰胺)暴露于雌性黑头呆鱼 24 h 的浓度反应(5 个浓度加对照)中。与基于 AOP 的预期一致,所有 3 种化学物质均导致血浆 E2 和肝 VTG 转录显著降低。来曲唑引起卵巢芳香酶和促滤泡激素受体(fshr)转录物的特征性补偿性上调,但其他 2 种化合物则没有。考虑到体内实验终点的浓度反应和时间一致性的整体模式,实验数据增强了 AOP 概述的定性关系的信心。从定量上看,qAOP 模型对来曲唑的预测与实测数据的标准误差相符,但对双氰胺和环氧氯丙烷的预测则不然。然而,将测试化学物质的实测血浆浓度作为输入纳入模型,提高了模型预测的准确性,所有预测值均在实测值范围内。结果突出了 qAOP 的实用性和局限性,及其在 21 世纪生态毒理学中的潜在应用。Environ Toxicol Chem 2021;40:1155-1170。 © 2020 SETAC。本文的作者为美国政府雇员,其作品在美国属于公有领域。